Literature DB >> 8471834

Expression of the c-ski proto-oncogene in human melanoma cell lines.

S Fumagalli1, L Doneda, N Nomura, L Larizza.   

Abstract

The aim of this study was to establish whether the expression of proto-oncogene c-ski in melanoma might be related to alterations of chromosome 1q involving the native location of the gene. Six melanoma cell lines, including two carrying marker chromosomes derived from breakage at 1q12-q21, were studied. Expression of c-ski was observed in all cell lines, with very high levels in five of them. However no alteration in c-ski structure or dosage was found in any of the melanoma cell lines, including those with non-random breakpoints near the gene. c-ski Transcripts were detected in cell cultures from normal melanocytes, but at a much lower level than that observed in melanoma cell lines. Transcripts of c-myb and the beta-NGF gene were not detectable in any of the melanoma cell lines, whereas sis- and epidermal growth factor (EGF) receptor gene-specific transcripts were present in two and four melanoma cell lines, respectively. The constant expression of c-ski in the melanoma-derived cell lines at a level of expression much higher than that of normal melanocytes suggests that this proto-oncogene may play a role in melanocyte transformation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471834     DOI: 10.1097/00008390-199304000-00004

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  22 in total

1.  Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells.

Authors:  W Wang; F V Mariani; R M Harland; K Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.

Authors:  S L Stroschein; S Bonni; J L Wrana; K Luo
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

3.  Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.

Authors:  Yi Chen; Lucia Pirisi; Kim E Creek
Journal:  Virology       Date:  2013-06-27       Impact factor: 3.616

4.  Identification of Ski as a target for Aurora A kinase.

Authors:  Jocelyn Mosquera; Ricardo Armisen; Hongling Zhao; Diego A Rojas; Edio Maldonado; Julio C Tapia; Alicia Colombo; Michael J Hayman; Katherine Marcelain
Journal:  Biochem Biophys Res Commun       Date:  2011-05-12       Impact factor: 3.575

5.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

6.  Biologic and therapeutic significance of MYB expression in human melanoma.

Authors:  N Hijiya; J Zhang; M Z Ratajczak; J A Kant; K DeRiel; M Herlyn; G Zon; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.

Authors:  BaoHan T Vo; Bianca Cody; Yang Cao; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2012-07-27       Impact factor: 4.944

8.  The crystal structure of the Dachshund domain of human SnoN reveals flexibility in the putative protein interaction surface.

Authors:  Tomas Nyman; Lionel Trésaugues; Martin Welin; Lari Lehtiö; Susanne Flodin; Camilla Persson; Ida Johansson; Martin Hammarström; Pär Nordlund
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma.

Authors:  Thomas Longerich; Kai Breuhahn; Margarete Odenthal; Katharina Petmecky; Peter Schirmacher
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

10.  Assessing the druggability of protein-protein interactions by a supervised machine-learning method.

Authors:  Nobuyoshi Sugaya; Kazuyoshi Ikeda
Journal:  BMC Bioinformatics       Date:  2009-08-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.